268 related articles for article (PubMed ID: 9383836)
1. The role of GnRH agonists plus add-back therapy in the treatment of endometriosis.
Gargiulo AR; Hornstein MD
Semin Reprod Endocrinol; 1997; 15(3):273-84. PubMed ID: 9383836
[TBL] [Abstract][Full Text] [Related]
2. Emerging drugs for endometriosis.
Fedele L; Berlanda N
Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
[TBL] [Abstract][Full Text] [Related]
3. Hormonal therapies for endometriosis: implications for bone metabolism.
Dawood MY
Acta Obstet Gynecol Scand Suppl; 1994; 159():22-34. PubMed ID: 8209669
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
[TBL] [Abstract][Full Text] [Related]
5. Add-back therapy in the treatment of endometriosis-associated pain.
Zupi E; Marconi D; Sbracia M; Zullo F; De Vivo B; Exacustos C; Sorrenti G
Fertil Steril; 2004 Nov; 82(5):1303-8. PubMed ID: 15533351
[TBL] [Abstract][Full Text] [Related]
6. "Add-back" therapy for endometriosis in adolescents.
Lubianca JN; Gordon CM; Laufer MR
J Reprod Med; 1998 Mar; 43(3):164-72. PubMed ID: 9564639
[TBL] [Abstract][Full Text] [Related]
7. Current approaches to optimizing the treatment of endometriosis in adolescents.
Laufer MR
Gynecol Obstet Invest; 2008; 66 Suppl 1():19-27. PubMed ID: 18936548
[TBL] [Abstract][Full Text] [Related]
8. [The ranking of the gestagens in the treatment of pain caused by endometriosis--an overview].
Schweppe KW
Zentralbl Gynakol; 2003; 125(7-8):276-80. PubMed ID: 14505263
[TBL] [Abstract][Full Text] [Related]
9. Endometriosis and the estrogen threshold theory. Relation to surgical and medical treatment.
Barbieri RL
J Reprod Med; 1998 Mar; 43(3 Suppl):287-92. PubMed ID: 9564663
[TBL] [Abstract][Full Text] [Related]
10. Add-back therapy in the treatment of endometriosis: the European experience.
Edmonds DK
Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():10-3. PubMed ID: 8916980
[TBL] [Abstract][Full Text] [Related]
11. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
Cedars MI; Lu JK; Meldrum DR; Judd HL
Obstet Gynecol; 1990 Apr; 75(4):641-5. PubMed ID: 2138265
[TBL] [Abstract][Full Text] [Related]
12. [GnRH agonist and add back therapy--indications, results and problems in the treatment of genital endometriosis].
Mettler L
Zentralbl Gynakol; 2003; 125(7-8):267-75. PubMed ID: 14505262
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?
Surrey ES
Curr Opin Obstet Gynecol; 2010 Aug; 22(4):283-8. PubMed ID: 20498596
[TBL] [Abstract][Full Text] [Related]
14. Immediate and delayed add-back hormonal replacement therapy during ultra long GnRH agonist treatment of chronic cyclical pelvic pain.
Al-Azemi M; Jones G; Sirkeci F; Walters S; Houdmont M; Ledger W
BJOG; 2009 Nov; 116(12):1646-56. PubMed ID: 19735378
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of GnRH agonist therapy. Review of clinical studies and their implications.
Agarwal SK
J Reprod Med; 1998 Mar; 43(3 Suppl):293-8. PubMed ID: 9564664
[TBL] [Abstract][Full Text] [Related]
16. Both GnRH agonist and continuous oral progestin treatments reduce the expression of the tyrosine kinase receptor B and mu-opioid receptor in deep infiltrating endometriosis.
Matsuzaki S; Canis M; Pouly JL; Botchorishvili R; Déchelotte PJ; Mage G
Hum Reprod; 2007 Jan; 22(1):124-8. PubMed ID: 17000647
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of endometriosis].
Römer T
Med Monatsschr Pharm; 2012 Feb; 35(2):44-51; quiz 53-4. PubMed ID: 22400429
[TBL] [Abstract][Full Text] [Related]
18. [Clinical efficacy and safety of gonadotropin releasing hormone agonist combined with estrogen-dydrogesteronea in treatment of endometriosis].
Long QQ; Zhang SF; Han Y; Chen H; Li XL; Hua KQ; Hu WG
Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):247-51. PubMed ID: 20646533
[TBL] [Abstract][Full Text] [Related]
19. [Estrogen-progesterone "add-back" for long-term GNRH analogue therapy].
Levy T; Ben-Rafael Z
Harefuah; 1995 Jun; 128(12):789-92. PubMed ID: 7557691
[No Abstract] [Full Text] [Related]
20. The role of add-back therapy in the United States.
Olive DL
Drugs Today (Barc); 2005 Jul; 41 Suppl A():23-6. PubMed ID: 16200222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
